Libra Infusions Ltd. reported unaudited earnings results for the first quarter ended September 30, 2016. For the year, the company reported loss per share of BDT 5.78 and NOCFPS of BDT 0.70 as against loss per share of BDT 7.66 and NOCFPS of BDT 0.90 for the same period of the previous year.